AstraZeneca Admits Vaccine Can Cause Thrombosis with Thrombocytopenia Syndrome
In a recent development, AstraZeneca, the pharmaceutical giant behind the Covid-19 AstraZeneca vaccine, has admitted that the vaccine can cause thrombosis with Thrombocytopenia Syndrome (TTS). This admission was made for the first time in court documents related to a class-action lawsuit filed against the company. The lawsuit alleges that certain recipients of the vaccine have experienced serious injuries or even death as a result.
One of the plaintiffs in this lawsuit is Jamie Scott, a father of two who suffered a blood clot that prevented him from working. Unfortunately, in April 2021, it was reported that he had suffered a permanent brain injury due to receiving the vaccine. This case is just one of the fifty-one cases filed in the High Court seeking damages up to £100 million.
Initially, AstraZeneca denied any connection between the vaccine and TTS. However, in a legal document submitted to the High Court in February, the company finally admitted that “the AZ vaccine can, in rare cases, cause TTS. The causal mechanism is unknown.” This admission comes three years after the vaccine was rolled out.
During an interview with The Telegraph, Kate, Scott’s wife, emphasized that the medical community has long recognized the link between vaccines and vaccine-induced immune thrombocytopenia and thrombosis (VITT). She expressed the need for an apology and compensation for their family and others affected by this incident.
It is worth noting that AstraZeneca had partnered with the Serum Institute of India (SII), the world’s largest vaccine manufacturer, to supply the vaccine to the Indian government. However, with this recent admission, questions arise about the safety and potential risks associated with the AstraZeneca vaccine.
In conclusion, AstraZeneca’s admission regarding the vaccine’s potential to cause TTS is a significant development in the ongoing class-action lawsuit. It validates the concerns raised by the plaintiffs and their families. Moving forward, it is crucial for transparency and accountability to ensure the safety of vaccines and protect public health.